Matches in Wikidata for { <http://www.wikidata.org/entity/Q58614658> ?p ?o ?g. }
Showing items 1 to 72 of
72
with 100 items per page.
- Q58614658 description "artículu científicu espublizáu en setiembre de 2011" @default.
- Q58614658 description "im Oktober 2011 veröffentlichter wissenschaftlicher Artikel" @default.
- Q58614658 description "scientific article published on 06 September 2011" @default.
- Q58614658 description "wetenschappelijk artikel" @default.
- Q58614658 description "наукова стаття, опублікована в жовтні 2011" @default.
- Q58614658 name "Phase I Pharmacokinetic and Pharmacodynamic Dose-Escalation Study of RG7160 (GA201), the First Glycoengineered Monoclonal Antibody Against the Epidermal Growth Factor Receptor, in Patients With Advanced Solid Tumors" @default.
- Q58614658 name "Phase I Pharmacokinetic and Pharmacodynamic Dose-Escalation Study of RG7160 (GA201), the First Glycoengineered Monoclonal Antibody Against the Epidermal Growth Factor Receptor, in Patients With Advanced Solid Tumors" @default.
- Q58614658 type Item @default.
- Q58614658 label "Phase I Pharmacokinetic and Pharmacodynamic Dose-Escalation Study of RG7160 (GA201), the First Glycoengineered Monoclonal Antibody Against the Epidermal Growth Factor Receptor, in Patients With Advanced Solid Tumors" @default.
- Q58614658 label "Phase I Pharmacokinetic and Pharmacodynamic Dose-Escalation Study of RG7160 (GA201), the First Glycoengineered Monoclonal Antibody Against the Epidermal Growth Factor Receptor, in Patients With Advanced Solid Tumors" @default.
- Q58614658 prefLabel "Phase I Pharmacokinetic and Pharmacodynamic Dose-Escalation Study of RG7160 (GA201), the First Glycoengineered Monoclonal Antibody Against the Epidermal Growth Factor Receptor, in Patients With Advanced Solid Tumors" @default.
- Q58614658 prefLabel "Phase I Pharmacokinetic and Pharmacodynamic Dose-Escalation Study of RG7160 (GA201), the First Glycoengineered Monoclonal Antibody Against the Epidermal Growth Factor Receptor, in Patients With Advanced Solid Tumors" @default.
- Q58614658 P1433 Q58614658-F16D83DF-F3FC-4AAC-9690-E2BE00A8B273 @default.
- Q58614658 P1476 Q58614658-5411D637-6F06-4E32-903A-FC896DB24DF1 @default.
- Q58614658 P2093 Q58614658-11C3368F-3ACF-4230-A5A5-7883247BCEDC @default.
- Q58614658 P2093 Q58614658-1BD2165D-E2BE-4D5B-897E-BFF211BB95EF @default.
- Q58614658 P2093 Q58614658-2921B8AE-C9F9-48B7-A6F3-3B795A4CAAB6 @default.
- Q58614658 P2093 Q58614658-5409954E-88F2-481F-8BE1-1A7159069996 @default.
- Q58614658 P2093 Q58614658-86F32C27-DC98-4AAF-9B72-B48C5D574A55 @default.
- Q58614658 P2093 Q58614658-8A4BF46D-5799-42B7-A8F8-3B4F6DA39948 @default.
- Q58614658 P2093 Q58614658-9D93AD15-92BF-46C2-BB6B-A8984CF0E24A @default.
- Q58614658 P2093 Q58614658-ADD616C4-511F-4C51-B483-C533C468584E @default.
- Q58614658 P2093 Q58614658-BEF9777F-5F86-4C81-BE7B-FA8532A1E9F5 @default.
- Q58614658 P2093 Q58614658-C6FB314A-BAF5-41EC-8563-C868A53CEFE3 @default.
- Q58614658 P2093 Q58614658-C792C534-3C0D-4C17-B537-F32A097CAFA9 @default.
- Q58614658 P2093 Q58614658-DC7E5D7D-698E-47B3-ACD8-24E9BC42E410 @default.
- Q58614658 P2093 Q58614658-E4CC7EDE-B9F9-4C81-B3EB-2CD90A7DE6E5 @default.
- Q58614658 P2093 Q58614658-F53B239B-B061-4E50-9E0C-7A56D5E92E66 @default.
- Q58614658 P304 Q58614658-F065B2FA-034F-4510-98FB-BA313CC27ADB @default.
- Q58614658 P31 Q58614658-D25C4B38-6CD7-43E9-9709-AC9797BE65F2 @default.
- Q58614658 P356 Q58614658-4E462BA2-ADA6-4F18-A482-260841492879 @default.
- Q58614658 P407 Q58614658-5F5F43E6-83F2-4D6C-BF3E-0EE86C0F533D @default.
- Q58614658 P433 Q58614658-AEABBC2A-6F9D-494A-A6A4-6834D9355E8B @default.
- Q58614658 P478 Q58614658-0BCF4D08-38A2-4C01-ACAE-2E96E238DBB5 @default.
- Q58614658 P50 Q58614658-7B5D44D8-3855-4403-8CDC-707688BC5C9B @default.
- Q58614658 P577 Q58614658-187AAD95-77E8-446C-8102-D1DE9B864540 @default.
- Q58614658 P698 Q58614658-B74A0713-072D-4EAC-A917-9CFEE94C90B7 @default.
- Q58614658 P921 Q58614658-099E6F7A-CCDA-4059-ACA2-8B1C8B5B831F @default.
- Q58614658 P921 Q58614658-43A6FCC9-E8A0-49BF-8160-350C7176FD90 @default.
- Q58614658 P921 Q58614658-74CD391B-D5D0-4F38-86DC-F423E660791E @default.
- Q58614658 P921 Q58614658-BF015DCC-9589-4FC2-A553-680143A254CC @default.
- Q58614658 P356 JCO.2011.34.8888 @default.
- Q58614658 P698 21900113 @default.
- Q58614658 P1433 Q400292 @default.
- Q58614658 P1476 "Phase I pharmacokinetic and pharmacodynamic dose-escalation study of RG7160 (GA201), the first glycoengineered monoclonal antibody against the epidermal growth factor receptor, in patients with advanced solid tumors" @default.
- Q58614658 P2093 "Andres Cervantes" @default.
- Q58614658 P2093 "Ben Markman" @default.
- Q58614658 P2093 "Carlos Gomez-Roca" @default.
- Q58614658 P2093 "Desamparados Roda" @default.
- Q58614658 P2093 "Fiona Russell-Yarde" @default.
- Q58614658 P2093 "Jean-Charles Soria" @default.
- Q58614658 P2093 "Jean-Pierre Delord" @default.
- Q58614658 P2093 "Jesus Corral" @default.
- Q58614658 P2093 "José Baselga" @default.
- Q58614658 P2093 "Luigi Manenti" @default.
- Q58614658 P2093 "Luis G Paz-Ares" @default.
- Q58614658 P2093 "Pablo Umana" @default.
- Q58614658 P2093 "Simon Hollingsworth" @default.
- Q58614658 P2093 "Yann Bergé" @default.
- Q58614658 P304 "3783-3790" @default.
- Q58614658 P31 Q13442814 @default.
- Q58614658 P356 "10.1200/JCO.2011.34.8888" @default.
- Q58614658 P407 Q1860 @default.
- Q58614658 P433 "28" @default.
- Q58614658 P478 "29" @default.
- Q58614658 P50 Q37387600 @default.
- Q58614658 P577 "2011-09-06T00:00:00Z" @default.
- Q58614658 P698 "21900113" @default.
- Q58614658 P921 Q323936 @default.
- Q58614658 P921 Q422248 @default.
- Q58614658 P921 Q725307 @default.
- Q58614658 P921 Q79460 @default.